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Background: Industrialised countries had varied responses to the 
coronavirus disease 2019 (COVID-19) pandemic, and how they 
adapted to new situations and knowledge since it began. These 
differences in preparedness and policy may lead to different death 
tolls from COVID-19 as well as other diseases.  
Methods: We applied an ensemble of 16 Bayesian probabilistic 
models to vital statistics data to estimate the impacts of the pandemic 
on weekly all-cause mortality for 40 industrialised countries from mid-
February 2020 through mid-February 2021, before a large segment of 
the population was vaccinated in these countries. 
Results: Over the entire year, an estimated 1,410,300 (95% credible 
interval 1,267,600-1,579,200) more people died in these countries 
than would have been expected had the pandemic not happened. This 
is equivalent to 141 (127-158) additional deaths per 100,000 people 
and a 15% (14-17) increase in deaths in all these countries combined. 
In Iceland, Australia and New Zealand, mortality was lower than would 
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be expected if the pandemic had not occurred, while South Korea and 
Norway experienced no detectable change in mortality. In contrast, 
the USA, Czechia, Slovakia and Poland experienced at least 20% higher 
mortality. There was substantial heterogeneity across countries in the 
dynamics of excess mortality. The first wave of the pandemic, from 
mid-February to the end of May 2020, accounted for over half of 
excess deaths in Scotland, Spain, England and Wales, Canada, 
Sweden, Belgium, the Netherlands and Cyprus. At the other extreme, 
the period between mid-September 2020 and mid-February 2021 
accounted for over 90% of excess deaths in Bulgaria, Croatia, Czechia, 
Hungary, Latvia, Montenegro, Poland, Slovakia and Slovenia.  
Conclusions: Until the great majority of national and global 
populations have vaccine-acquired immunity, minimising the death 
toll of the pandemic from COVID-19 and other diseases will require 
actions to delay and contain infections and continue routine health 
care.
Keywords 
Excess mortality, Covid-19, SARS-CoV-2, Bayesian ensemble modelling, 
autoregressive models, uncertainty.
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Introduction
Many industrialised countries experienced a rise in all-cause mor-
tality in the first wave of the coronavirus disease 2019 (COVID-
19) pandemic, while others avoided any excess deaths1. These 
excess deaths were due to infection with severe acute respira-
tory syndrome coronavirus 2 (SARS-CoV-2), delays and disrup-
tions in the provision and use of healthcare for other diseases, 
loss of jobs and income, disruptions of social networks and 
support, and changes in nutrition, drug and alcohol use, 
transportation, crime, and violence2,3.
Decline in infections following initial lockdowns and other 
restrictions, and advances in knowledge about the SARS-CoV-2 
transmission and infection, presented a window of opportu-
nity for countries to implement pandemic control measures and 
strengthen health and social care provision that would minimise 
the impacts of subsequent waves4,5. Comparative analysis of 
excess deaths helps understand how effectively these measures 
were implemented and how resilient the health and social care 
system was in each country. We quantified the weekly mortality 
impacts of the first year of the COVID-19 pandemic, from mid-
February 2020 to mid-February 2021, in 40 industrialised 
countries, listed below. We used this period because mortality 
due to the pandemic was negligible before mid-February 
20201, and vaccination rates against SARS-CoV-2 were still 
relatively low before mid-February 2021 in these countries 
(no more than 4% of the population had received both 
doses in any of these countries, as per Our World in Data). 
After mid-February 2021, the effect of vaccines on mortality 
was expected to appear in some countries, which should 
be subject to a distinct analysis.
Methods
Data sources
We included industrialised countries with complete or 
near-complete registration of deaths in our analysis if:
•    Their total population in 2020 was more than 100,000. 
We excluded countries (e.g., Liechtenstein) with data 
but with smaller populations because, in many weeks, 
the number of deaths would be small or zero. This 
would, in turn, lead to either large uncertainty that would 
make it hard to differentiate between those places with 
and without an effect or unstable estimates because the 
model is fitted to many weeks with zero deaths.
•    We could access up-to-date weekly data on all-
cause mortality divided by age group and/or sex that 
extended through February 2021.
•    The time series of data went back at least to the begin-
ning of 2016 so that model parameters could be reliably 
estimated. For countries with longer time series, we used 
data starting in 2010.
The 40 countries in our analysis were divided into five geographi-
cal regions: the Pacific (Australia, New Zealand, South Korea), 
the Americas (Canada, Chile, the USA), Central and Eastern 
Europe (Austria, Bulgaria, Croatia, Czechia, Estonia, Hungary, 
Latvia, Lithuania, Montenegro, Poland, Romania, Serbia, 
Slovakia, Slovenia), Southwestern Europe (Cyprus, France, 
Greece, Italy, Malta, Portugal, Spain), Northwestern Europe 
(Belgium, England and Wales, Germany, Luxembourg, the 
Netherlands, Northern Ireland, Scotland, Switzerland) and 
Nordic (Denmark, Finland, Iceland, Norway, Sweden). In addition 
to national estimates, we separately estimated excess deaths for 
all 50 US states and the District of Columbia, some of which 
are larger than most other countries included in our analysis, 
because the extent and temporal dynamics of the pandemic 
were heterogeneous across states.
The sources of population and mortality data are provided 
in Table 1. We calculated weekly population through inter-
polation of yearly population, consistent with the approach 
taken by national statistical offices for intra-annual population 
calculation6. Population for 2020 and 2021, where not available, 
was obtained through linear extrapolation from the last five 
years. We obtained data on temperature from ERA57, which 
uses data from global in situ and satellite measurements to 
generate a worldwide meteorological dataset, with full space 
and time coverage over our analysis period. We used gridded 
temperature estimates measured four times daily at a resolution 
of 30 km to generate weekly temperatures for each first-level 
administrative region, and gridded population data to generate 
population estimates by first-level administrative region in 
each country. We weighted weekly temperature by population 
of each first-level administrative region to create national 
level weekly temperature summaries.
Statistical methods
We used a probabilistic model averaging approach to estimate 
what death rates were expected to be over this period had the 
pandemic not occurred, and compared these estimates with actual 
deaths from all causes in each country. The analytical method 
was designed to enhance comparison across countries and 
over time, and account for medium-long-term secular trends in 
mortality, the potential dependency of death rates in each week 
on those in preceding week(s) and in each year on those in 
preceding year(s), and factors that affect mortality including 
seasonality, temperature and public holidays.
The total mortality impact of the COVID-19 pandemic is the 
difference between the observed number of deaths from all 
causes of death and the number of deaths had the pandemic not 
occurred, which is not directly measurable. The most com-
mon approach to calculating the number of deaths had the pan-
demic not occurred has been to use the average number of deaths 
over previous years, e.g., the most recent five years, for the 
corresponding week or month when the comparison is made. 
This approach however does not take into account long- and 
short-term trends in mortality or time-varying factors like 
temperature, that are largely external to the pandemic, but 
also affect death rates.
We developed an ensemble of 16 Bayesian mortality projec-
tion models that each make an estimate of weekly death rates 
that would have been expected if the COVID-19 pandemic had 
not occurred8. We used multiple models because there is inher-
ent uncertainty in the choice of model that best predicts death 
rates in the absence of pandemic. These models were formulated 
to incorporate features of weekly death rates, and how they 
behave in the short-term (week to week) and medium-term 
(year to year), as follows:
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Table 1. Sources of data on deaths and population.
Data sources for deaths 
and population
Start of time 
series
Sex-specific analysis (see 
Methods for details)
Analysis age groups (see 
Methods for details)
Australia ABS1, UN2 29/12/2014 Y 0-44, 45-64, 65+
Austria Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
Belgium Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
Bulgaria Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
Canada StatCan5,6 09/01/2010 Y 0-44, 45-64, 65+
Chile MINSAL7, UN2 01/01/2016 Y 0-44, 45-64, 65+
Croatia Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
Cyprus Eurostat3,4 29/12/2014 Y 0-64, 65+
Czechia Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
Denmark Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
England and 
Wales8
ONS9,10 02/01/2010 Y 0-44, 45-64, 65+
Estonia Eurostat3,4 04/01/2010 Y 0-64, 65+
Finland Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
France Eurostat3,4 31/12/2012 Y 0-44, 45-64, 65+
Germany Destatis11, Eurostat4 04/01/2016 Y 0-44, 45-64, 65+
Greece Eurostat3,4 29/12/2014 Y 0-44, 45-64, 65+
Hungary Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
Iceland Eurostat3,4 04/01/2010 N All ages
Italy Eurostat3,4 03/01/2011 Y 0-44, 45-64, 65+
Latvia Eurostat3,4 04/01/2010 Y 0-64, 65+
Lithuania Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
Luxembourg Eurostat3,4 04/01/2010 Y 0-64, 65+
Malta Eurostat3,4 03/01/2011 N All ages
Montenegro Eurostat3,4 04/01/2010 Y 0-64, 65+
Netherlands Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
New Zealand Stats NZ12, UN2 02/01/2011 Y 0-64, 65+
Northern 
Ireland8
NISRA13, Eurostat4 01/01/2011 N 0-64, 65+
Norway Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
Poland Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
Portugal Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
Romania Eurostat3,4 29/12/2014 Y 0-44, 45-64, 65+
Scotland8 NRS14, ONS10 04/01/2010 Y 0-44, 45-64, 65+
Serbia Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
Slovakia Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
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•    First, death rates may have a medium-to-long-term 
trend9 that would lead to a lower or higher mortality 
in 2020-2021 compared to earlier years. Therefore, all 
models included a linear trend term over weekly death 
rates.
•    Second, death rates have a seasonal pattern10–13. We 
included weekly random intercepts for each week of the 
year. To account for the fact that seasonal patterns “repeat” 
(i.e., late December and early January are seasonally 
similar) we used a seasonal structure14,15 for the random 
intercepts. The seasonal structure allows the magnitude 
of the random intercepts to vary over time, and implic-
itly incorporates time-varying factors such as annual 
fluctuations in flu season.
•    Third, death rates in each week may be related to rates in 
preceding week(s), due to short-term phenomena such 
as severity of the flu season. We formulated four sets 
of models to account for this relationship. The weekly 
random intercepts in these models had a first, second, 
fourth or eighth order autoregressive structure14,15. The 
higher-order autoregressive models allow death rates 
in any week to be informed by those in a progressively 
larger number of preceding weeks. Further, trends not 
picked up by the linear or seasonal terms would be 
captured by these autoregressive terms.
•    Fourth and additionally, mortality in one year may depend 
on mortality in the previous year, in a different way 
for each month, because phenomena such as seasonal 
flu may lead to longer-term dependencies in mortality. 
To allow for this possibility, we used two sets of 
models, with and without a first order autoregressive 
term over years for each month.
•    Fifth, beyond having a seasonal pattern, death rates 
depend on temperature, and specifically on whether 
Data sources for deaths 
and population
Start of time 
series
Sex-specific analysis (see 
Methods for details)
Analysis age groups (see 
Methods for details)
Slovenia Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
South Korea KOSIS15 03/01/2010 N 0-64, 65+
Spain Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
Sweden Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
Switzerland Eurostat3,4 04/01/2010 Y 0-44, 45-64, 65+
USA CDC16,17 04/01/2015 N 0-44, 45-64, 65+18
1 https://www.abs.gov.au/statistics/health/causes-death/provisional-mortality-statistics/latest-release
2 https://population.un.org/wpp
3 https://ec.europa.eu/eurostat/data/database (table demo_r_mwk_05). Deaths with unknown age (0.03% of all deaths) were distributed 
across age groups proportional to the overall distribution of deaths for each year and month.
4 https://ec.europa.eu/eurostat/data/database (table demo_pjangroup)
5 https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310076801. Death counts rounded to a neighbouring multiple of 5. There were 
no data for Yukon from 2017 to 2021 (before 2017, there were <10 deaths per week in Yukon).
6 https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1710000501
7 https://deis.minsal.cl/#datosabiertos. Deaths with unknown age and/or sex (0.02% of all deaths) were distributed across age groups 
and sexes proportional to the overall distribution of deaths for each year and month.
8 Data for the constituent nations in the UK are provided separately by NISRA for Northern Ireland, NRS for Scotland and ONS for 
England and Wales. These datasets use different reporting week definitions and could therefore not be combined into a single time 












15 https://kosis.kr/covid_eng/statistics_excessdeath.do and https://mdis.kostat.go.kr/index.do
16 https://data.cdc.gov/NCHS/Weekly-counts-of-deaths-by-jurisdiction-and-age-gr/y5bj-9g5w. We used deaths adjusted for completeness 
by the CDC which account for potential underreporting in the most recent weeks. The adjustment methods are described at https://
www.cdc.gov/nchs/nvss/vsrr/covid19/tech_notes.htm.
17 https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm
18 When analysing individual states, we merged 0–44 and 45–64 age groups into a single age group 0-64 years for Alaska, Delaware, 
DC, Hawaii, Idaho, Maine, Montana, Nebraska, New Hampshire, North Dakota, Rhode Island, South Dakota, Vermont West Virginia and 
Wyoming for reasons described in Methods.
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temperature is higher or lower than its long-term norm 
during a particular time of year16–21. The effect of 
temperature on mortality varies throughout the year, 
and may be in opposite directions for different times 
of year. We used two sets of models, one without tem-
perature and one with a weekly term for temperature 
anomaly, defined as deviation of weekly temperature 
from the local average weekly temperature over the 
entire analysis period.
•    Finally, death rates may be different around major holi-
days such as Christmas and New Year either because of 
changes in human activities and behaviour or, for the 
countries whose data are registration based, because 
of delays in registration. We included effects (as fixed 
intercepts) for the weeks containing Christmas and New 
Year in all countries. For England and Wales, Scotland 
and Northern Ireland, we also included effects for the 
week containing other public holidays, because reported 
death rates in weeks that contain a holiday were dif-
ferent from other weeks. This term was tested but not 
included for other countries because the effect was 
negligible.
These choices led to an ensemble of 16 Bayesian models 
(2 yearly autoregressive options × 4 weekly autoregressive 
options × 2 temperature anomaly options). The ensemble of 
models is shown in Table 2. In each model, the number of 
weekly deaths follows a Poisson distribution:
       
week week weekdeaths ~ Poisson(death rate population ).⋅
Table 2. Combination of terms used in each of the 16 models for estimating number of weekly deaths that would be 












specific term over years
Temperature anomaly 
terms
1 α0 + αholiday(week) β·week ζ
(1)
week θweek - -
2 α0 + αholiday(week) β·week ζ
(1)
week θweek - (γ + vweek of year) ·temperature 
anomalyweek
3 α0 + αholiday(week) β·week ζ
(1)
week θweek ηmonthyear -
4 α0 + αholiday(week) β·week ζ
(1)
week θweek ηmonthyear (γ + vweek of year) ·temperature anomalyweek
5 α0 + αholiday(week) β·week
(2)
weekζ θweek - -
6 α0 + αholiday(week) β·week
(2)
weekζ θweek - (γ + vweek of year) ·temperature 
anomalyweek
7 α0 + αholiday(week) β·week
(2)
weekζ θweek ηmonthyear -
8 α0 + αholiday(week) β·week
(2)
weekζ θweek ηmonthyear (γ + vweek of year) ·temperature anomalyweek
9 α0 + αholiday(week) β·week
(4)
weekζ θweek - -
10 α0 + αholiday(week) β·week (4)weekζ θweek - (γ + vweek of year) ·temperature anomalyweek
11 α0 + αholiday(week) β·week
(4)
weekζ θweek ηmonthyear -
12 α0 + αholiday(week) β·week
(4)
weekζ θweek ηmonthyear (γ + vweek of year) ·temperature anomalyweek
13 α0 + αholiday(week) β·week (8)weekζ θweek - -
14 α0 + αholiday(week) β·week (8)weekζ θweek - (γ + vweek of year) ·temperature anomalyweek
15 α0 + αholiday(week) β·week (8)weekζ θweek ηmonthyear -
16 α0 + αholiday(week) β·week (8)weekζ θweek ηmonthyear (γ + vweek of year) ·temperature anomalyweek
1 Due to the short duration of the time series, the holiday term was not identifiable for Chile (in the presence of the seasonal term) and was therefore 
not included.
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Log-transformed death rates were modelled as a sum of 
components described above:
( ) month
week 0 holiday(week) week year
week week of year week week
log (death rate ) = + + +
( ) temperature anomaly
iα α β ⋅ η
+ θ + γ + ν ⋅ + ε
 week + ζ
The term α
0
 denotes the overall intercept and α
holiday(week)
 
is the holiday intercept, applied to weeks with a holiday. 





. For weeks that did not contain a holi-
day, this term did not appear in the above expression. All 
intercepts were assigned 𝒩(0,1000) priors. The term β ⋅ week 
represents the linear time trend. The coefficient β was also 
assigned a 𝒩(0,1000) prior.
The models used different orders (first, second, fourth or 
eighth) of the autoregressive term ζ( )week
i
 with the superscript i 
denoting the order for weekly mortality patterns. The first-
order autoregressive term is defined as ζ(1)week ~ 𝒩 (
(1) 2
week 1,σ−ϕ ⋅ ζ ζ ) 
where the parameter φ lies between -1 and 1 and captures 
the degree of association between the number of deaths in 
each week and the preceding week. Hyperpriors are placed on 
the parameters ϰ
1
 = log ((1–φ2)/ 2σ ζ ) and ϰ2 = log ((1+φ)/(1–φ)) 
which were assigned logGamma(0.001,0.001) and 𝒩(0,1) 
distributions respectively. Similarly, an ith order autoregres-
sive term is given by ( ) ( ) ( )1 week 1 week weekweek ...
i i i
i i− −= ϕ ⋅ + + ϕ ⋅ + εζ ζ ζ
with –1 < ϕ
j
 < 1. The parametrisation of these models was based 





yearη  is an autoregressive term of order 1 over years 
and independent across months, indexed to the month and year 
to which each particular week belongs. For each month, the 
autoregressive prior for 
month
yearη was the same as that for ζ
(1)
week 




 captures seasonality in mortality trends with 





 + ... + θ
week+51
 were modelled as independ-
ent Gaussian with zero mean and variance 
2
θσ . We used a 
logGamma(0.001,0.001) prior on the log precision log(1/
2
θσ ). 
Each week is assigned an index between 1 and 52 depend-
ing on which week of the current year it is (the incomplete 
week 53 is mapped to either index 1 or 52 depending on 
whether it has greater overlap with week 52 of the current year 
or week 1 of the following year).
The effect of temperature anomaly on death rates is cap-
tured by the two terms γ and ν
week of year
. The term γ⋅temperature 
anomaly
week
 is the overall association between (log-transformed) 





 captures deviations from 
the overall association for each week of the year. It consists 
of 52 terms with an independent and identically distributed 
prior defined via ν
week of year
 ~ 𝒩(0, 2νσ ), and log-precision 
log(1/
2
νσ ) ~ logGamma(0.001,0.001).
Finally, the term ε
week
 is a zero-mean term that accounts for addi-
tional variability. It is assigned an independent and identically 
distributed prior ε
week
 ~ 𝒩(0, 2εσ ), and a logGamma(0.001,0.001) 









 and ζ( )week
i
 (for autoregres-
sive order i = 1,2,4 or 8) appear in the expression for log(death 
rate
week
) in all models. The remaining components appear in 
some models only. Table 2 shows the terms included in each of 
the 16 models in the ensemble.
We used data on weekly deaths from the start of time series 
through mid-February 2020 to estimate the parameters of each 
model, which were then used to predict death rates for the sub-
sequent 52 weeks as estimates of the counterfactual death 
rates if the pandemic had not occurred. These were then com-
pared to reported deaths to calculate excess mortality due to 
the pandemic. For the projection period, we used recorded 
temperature so that our projections take into consideration 
actual temperature in 2020-2021. This choice of training and 
prediction periods assumes that the number of deaths that are 
directly or indirectly related to the COVID-19 pandemic was 
negligible through mid-February 2020 in these countries1, 
and separates the training data from subsequent weeks when 
impacts may have appeared.
All models were fitted using integrated nested Laplace approxi-
mation (INLA)23, implemented in the R-INLA software (ver-
sion 20.03). We used a model averaging approach to combine 
the predictions from the 16 models in the ensemble24,25. Spe-
cifically, we took 2,000 draws from the posterior distribution of 
predicted deaths under each of the 16 models, and pooled the 
32,000 draws to obtain the posterior distribution of deaths if the 
COVID-19 pandemic had not taken place. This approach gener-
ates a distribution of estimates that has equal samples from each 
model in the ensemble, and hence incorporates both the uncer-
tainty of estimates from each model and the uncertainty in the 
choice of model. The reported credible intervals represent the 
2.5th and 97.5th percentiles of the resultant posterior distribu-
tion of the draws from the entire ensemble. We report the 
number of excess deaths, excess deaths per 100,000 people, 
and relative (percent) increase in deaths together with their cor-
responding 95% credible intervals. For the purpose of report-
ing, we rounded results on number of deaths that are 1,000 or 
more to the nearest hundred to avoid giving a false sense of 
precision in the presence of uncertainty; results less than 1,000 
were rounded to the nearest ten. We also report the posterior 
probability that an estimated increase (or decrease) in deaths cor-
responds to a true increase (or decrease). Posterior probability 
represents the inherent uncertainty in how many deaths would 
have occurred in the absence of the pandemic. In a country and 
week in which the actual number of deaths is the same as the 
posterior median of the number expected in a no-pandemic coun-
terfactual, an increase in deaths is statistically indistinguishable 
from a decrease; in such a situation, there is a 50% posterior 
probability of an increase and a 50% posterior probability of a 
decrease. Where the entire posterior distribution of the number 
of deaths expected without the pandemic is smaller than the 
actual number of deaths, there is a ~100% posterior probabil-
ity of an increase and a ~0% posterior probability of a decrease 
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and vice versa. For most countries and weeks, the posterior dis-
tribution of the number of deaths expected without the pandemic 
covers the observed number, but there is asymmetry in terms of 
whether much of the distribution is smaller or larger than the 
observed number. In such cases, there would be uneven posterior 
probabilities of an increase versus decrease in deaths, with the 
two summing to 100% (for example, 80% and 20%). Posterior 
probabilities more distant from 50%, toward either 0% or 100%, 
indicate more certainty. 
We did all analyses separately by sex and age group (0–44 
years, 45–64 years, 65+ years) for countries with 2020 popula-
tion of at least two million, where age- and sex-specific data 
were available (Table 1). For countries with 2020 popula-
tion less than 2 million, we did our analyses for two age groups 
(0–64 years and 65+ years) because, in many weeks, the 
number of deaths in the age group 0-44 would be small or zero, 
which would lead to either large uncertainty or unstable esti-
mates. For the same reason, for countries with population under 
500,000 (Iceland and Malta), we did our analyses for both sexes 
and all age groups combined. Models were also run for all 
ages and both sexes combined; the posterior medians of resultant 
estimates were nearly identical to the sum of the age-sex-specific 
ones, with a mean relative difference of 0.2%, ranging from 
-1.7% to 1.1%. For this reason, in figures and tables that are for 
all ages and both sexes, we report results from the combined 
model so that the uncertainty of the estimates is correctly reported.
We report results for the entire year, as well as for three 
non-overlapping periods: the first wave of the pandemic 
(from mid-February 2020 through end of May), the (northern 
hemisphere) summer period (from beginning of June to 
mid-September 2020) and subsequent wave(s) (from 
mid-September 2020, when schools normally open in the 
northern hemisphere, to mid-February 2021).
Validation of no-pandemic counterfactual weekly 
deaths
We tested how well our model ensemble estimates the number 
of deaths expected had the pandemic not occurred by withhold-
ing data for 52 weeks starting from mid-February (i.e., the same 
projection period as done for 2020–2021) for an earlier year 
and using the preceding time series of data to train the models. 
In other words, we created a situation akin to 2020–2021 for 
an earlier year. We then projected death rates for the weeks 
with withheld data, and evaluated how well the model ensemble 
projections reproduced the known-but-withheld death rates. We 
repeated this for three different periods: 2017–2018 (i.e., train 
model using data from January 2010 to mid-February 2017 and 
test for the subsequent 52 weeks), 2018–2019 (i.e., train model 
using data from January 2010 to mid-February 2018 and test 
for the subsequent 52 weeks), and 2019–2020 (i.e., train model 
using data from January 2010 to mid-February 2019 and test for 
the subsequent 52 weeks). We performed these tests for each 
country using data for both sexes and all ages. We report the 
projection error (which measures systematic bias) and absolute 
projection error (which measures any deviation from the data). 
Additionally, we report coverage of the projection uncertainty; 
if projected death rates and their uncertainties are well esti-
mated, the estimated 95% credible intervals should cover 95% 
of the withheld data.
The results of model validation (Table 3) show that the esti-
mates of how many deaths would be expected had the pandemic 
not occurred from the Bayesian model ensemble were unbiased, 
with mean relative projection errors of 1.5% (between 0.5% 
and 2.2% in different years). The mean relative absolute error 
was between 8.0% and 8.7% in different years. 95% coverage, 
which measures how well the posterior distributions of projected 
deaths coincide with withheld data was 96% for all years, 
which shows that the posterior distribution is well estimated.
An earlier version of this manuscript can be found on medRxiv 
(doi: https://doi.org/10.1101/2021.07.12.21260387).
Results
Excess mortality between mid-February 2020 and  
mid-February 2021
Taken over the entire year, both sexes and all ages, an esti-
mated 1,410,300 (95% credible interval 1,267,600–1,579,200) 
more people died in these 40 countries than would have been 
expected had the pandemic not taken place. This is equiva-
lent to 141 (127–158) additional deaths per 100,000 people 
and a 15% (14–17) increase in deaths over this period in all of 
Table 3. Results of the external predictive validity (out-of-sample validation) of the 
estimated no-pandemic counterfactual weekly deaths from the Bayesian model 








error (relative absolute 
projection error)
Percent covered by 
95% credible interval
2017 1,893 (1.8%) 9,488 (8.5%) 97%
2018 1,107 (0.5%) 9,455 (8.7%) 94%
2019 3,306 (2.2%) 8,645 (8.0%) 98%
All three years 2,102 (1.5%) 9,196 (8.4%) 96%
* Australia, Chile, Cyprus, Germany, Greece, Romania and USA were not used for validation analysis 
because they had shorter time series. Hence leaving out the last three years of data would leave a time 
series that was too short for estimating model parameters.
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these countries combined. The number of deaths assigned to 
COVID-19 in these countries over the same period was 1,256,861, 
which is 89% of the excess all-cause death toll (Table 4). The 
number of excess deaths were largest in the USA (623,100; 
521,200-750,700), followed by Italy (118,800; 88,500-149,300) 
and England and Wales (102,100; 75,300-128,600) (Figure 1 
and Table 4). Within the USA, California (71,800; 64,100-79,500) 
and Texas (57,400; 48,100-67,200) experienced the larg-
est number of excess deaths, about the same as excess deaths in 
Spain and France, respectively (Figure 2).
In Iceland, Australia and New Zealand, mortality was 3-6% 
lower over this period than what would be expected if the pan-
demic had not occurred, with posterior probabilities of the 
estimated decrease being a true decrease ranging 82-94% 
(Figure 3). South Korea and Norway experienced no detectable 
change in mortality (54% and 74% probability of an increase 
respectively, with posterior median estimated increases <2%), 
and Finland, Greece, Cyprus and Denmark experienced increases 
of 2-5% (Figure 3A), with posterior probabilities that these 
changes represent an increase in death ranging from 84% 
to 97%. At the other extreme, the populations of the USA, 
Czechia, Slovakia and Poland experienced at least 20% higher 
mortality over these 52 weeks than they would have had the 
Table 4. Number of excess deaths from any cause and 
deaths assigned to coronavirus disease 2019 (COVID-19) due 
from mid-February 2020 to mid-February 2021, by country. 
Excess deaths ≥1,000 are rounded to the nearest hundred and 
excess deaths <1,000 to the nearest ten. Deaths assigned to 
COVID-19 were taken directly from the cited sources and not 
rounded.








Australia -4,090 (-11,590 to 2,300) 909
Austria 9,100 (4,900 to 13,200) 8,385
Belgium 17,900 (12,300 to 23,600) 22,077
Bulgaria 18,200 (12,800 to 23,500) 9,854
Canada 19,800 (8,800 to 31,300) 21,723
Chile 18,400 (15,200 to 21,600) 20,126
Croatia 6,400 (3,300 to 9,400) 5,449
Cyprus 140 (-520 to 840) 232
Czechia 24,000 (18,500 to 29,300) 19,777
Denmark 2,400 (-170 to 5,100) 2,343
England and Wales 102,100 (75,300 to 128,600) 128,077
Estonia 790 (140 to 1,500) 535








Finland 1,200 (-450 to 2,800) 756
France 62,700 (33,200 to 95,100) 84,306
Germany 64,100 (-1,870 to 135,400) 67,903
Greece 3,700 (-4,180 to 11,000) 6,297
Hungary 14,300 (7,500 to 21,300) 14,347
Iceland -140 (-340 to 40) 29
Italy 118,800 (88,500 to 149,300) 95,718
Latvia 2,200 (1,100 to 3,400) 1,542
Lithuania 6,600 (4,500 to 8,700) 3,178
Luxembourg 390 (150 to 640) 625
Malta 320 (20 to 640) 304
Montenegro 950 (530 to 1,400) 950
Netherlands 17,300 (9,400 to 25,300) 15,231
New Zealand -1,050 (-3,390 to 1,300) 26
Northern Ireland 2,300 (1,300 to 3,300) 2,751
Norway 490 (-1,090 to 2,100) 608
Poland 82,300 (62,500 to 101,400) 42,171
Portugal 20,700 (14,100 to 27,200) 15,962
Romania 45,600 (30,800 to 61,500) 19,894
Scotland 7,100 (3,600 to 10,600) 9,355
Serbia 10,300 (5,600 to 14,800) 4,337
Slovakia 11,300 (8,200 to 14,200) 6,671
Slovenia 3,600 (2,700 to 4,400) 4,057
South Korea 560 (-10,870 to 11,000) 1,562
Spain 76,100 (52,400 to 100,100) 67,636
Sweden 9,900 (6,400 to 13,700) 12,914
Switzerland 10,200 (7,100 to 13,300) 9,174
USA 623,100 (521,200 to 
750,700)
529,070
1 Data are from Office for National Statistics for England and 
Wales (https://www.ons.gov.uk/ peoplepopulationandcommunity/
birthsdeathsandmarriages/deaths/datasets/
weeklyprovisionalfiguresondeathsregisteredinenglandandwales), NRS for 
Scotland (https://www.nrscotland.gov.uk/covid19stats), NISRA for Northern 
Ireland (https://www.nisra.gov.uk/system/files/statistics/Weekly_Deaths%20-
%20w%20e%203rd%20September%202021.XLSX) and the European Centre 
for Disease Prevention and Control (ECDC) for other countries (https://
opendata.ecdc.europa.eu/covid19/nationalcasedeath/csv; accessed on 21 
September 2021).
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Figure 1. Number of excess deaths due to the first year of the coronavirus disease 2019 (COVID-19) pandemic by country. The 
size of each rectangle shows the number of deaths from all causes in excess of what would be expected if there had been no COVID-
19 pandemic from mid-February 2020 through mid-February 2021 for each country. There are no segments for Australia, New Zealand, 
Norway, Iceland and South Korea because we estimated no detectable excess deaths or a potential reduction in mortality compared to 
the no-pandemic baseline. Colour for each country indicates its geographical region: the Pacific (Australia, New Zealand, South Korea), 
the Americas (Canada, Chile, the USA), Central and Eastern Europe (Austria, Bulgaria, Croatia, Czechia, Estonia, Hungary, Latvia, Lithuania, 
Montenegro, Poland, Romania, Serbia, Slovakia, Slovenia), Southwestern Europe (Cyprus, France, Greece, Italy, Malta, Portugal, Spain), 
Northwestern Europe (Belgium, England and Wales, Germany, Luxembourg, the Netherlands, Northern Ireland, Scotland, Switzerland) and 
Nordic (Denmark, Finland, Iceland, Norway, Sweden). 
Figure 2. Number of excess deaths due to the first year of the coronavirus disease 2019 (COVID-19) pandemic by US state. The 
size of each rectangle shows the number of deaths from all causes in excess of what would be expected if there had been no COVID-19 
pandemic from mid-February 2020 through mid-February 2021 for each state and the District of Columbia. There is no segment for Hawaii 
because we estimated no detectable excess deaths. The colour of each state indicates its geographical region: Alabama, Florida, Georgia, 
North Carolina, South Carolina, Virginia (Southeast); Alaska, Idaho, Oregon, Washington (Northwest); Arizona, Colorado, New Mexico, Utah 
(Southwest); Arkansas, Kansas, Louisiana, Mississippi, Oklahoma, Texas (South); California, Nevada (West); Connecticut, Delaware, District 
of Columbia, Maine, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont (Northeast); 
Illinois, Indiana, Kentucky, Missouri, Ohio, Tennessee, West Virginia (Central); Iowa, Michigan, Minnesota, Wisconsin (East North Central); and 
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pandemic not occurred; the increase was between 15% and 
20% in England and Wales, Italy, Portugal, Spain, Romania, 
Slovenia, Lithuania, Bulgaria, Chile, Belgium and Switzerland; 
the posterior probabilities that these countries experienced 
an increase in deaths were >99%. Because baseline mortality 
(i.e., death rates expected without the pandemic) varied across 
countries, the ordering of countries in terms of excess deaths 
per 100,000 people (Figure 3B) differed from the ranking 
of percent increase. Bulgaria, Romania, Lithuania, Czechia, 
Poland, Slovakia and Portugal experienced more than 200 
excess deaths per 100,000 people and Italy, USA, England and 
Wales, Slovenia, Spain, Croatia, Belgium and Montenegro 
between 150 and 200, all with posterior probabilities of an 
increase in deaths >99%. There was as much variation in excess 
mortality across US states as across the 40 countries together, 
with Hawaii having experienced the same level of mortal-
ity as would have been expected without the pandemic, Maine a 
5% increase, and, at the other extreme, New Jersey, Arizona, 
Mississippi, Texas, California, Louisiana and New York at 
least 25% higher mortality over this year (Figure 4).
Figure 3. Excess mortality due to the first year of the coronavirus 2019 (COVID-19) pandemic, by country. (A) Posterior distribution 
of percent increase in deaths from any cause from mid-February 2020 to mid-February 2021. Gold dots show the posterior medians. 
(B) Posterior distribution of excess deaths from any cause per 100,000 people from mid-February 2020 to mid-February 2021. Gold dots 
show the posterior medians. In both panels, the right-hand side shows the probability distribution for the country’s rank. Countries are 
ordered vertically by median increase from smallest (at the bottom) to the largest (at the top). Colour for each country’s name indicates 
its geographical region: the Pacific (Australia, New Zealand, South Korea), the Americas (Canada, Chile, the USA), Central and Eastern 
Europe (Austria, Bulgaria, Croatia, Czechia, Estonia, Hungary, Latvia, Lithuania, Montenegro, Poland, Romania, Serbia, Slovakia, Slovenia), 
Southwestern Europe (Cyprus, France, Greece, Italy, Malta, Portugal, Spain), Northwestern Europe (Belgium, England and Wales, Germany, 
Luxembourg, the Netherlands, Northern Ireland, Scotland, Switzerland) and Nordic (Denmark, Finland, Iceland, Norway, Sweden). See 
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Dynamics of excess mortality
There was substantial heterogeneity across countries in terms 
of the patterns and dynamics of excess mortality over time 
(Figure 5 and Figure 6). Some countries in Central and Eastern 
Europe – Bulgaria, Lithuania, Poland, Romania, Serbia and 
Montenegro – had no or little excess mortality in the first wave 
of the pandemic (mid-February 2020 to end of May 2020), but 
experienced between 5% and 13% increase in mortality during 
the (northern hemisphere) summer (June 2020 to mid-September 
2020; Figure 7A). In contrast, some countries with medium 
or high levels of excess mortality in the first wave returned 
to death rates in the summer that were about the same as the 
no-pandemic baseline (England and Wales, Belgium, Scotland, 
Northern Ireland, Sweden, Netherlands, France, Switzerland, 
Luxembourg and Cyprus) or only slightly higher than this 
baseline (Canada, Italy and Spain). Portugal and the USA 
experienced a similar increase in mortality over the summer 
– 10% (1-21) and 17% (12-24), respectively – to what they 
Figure 4. Excess mortality due to the first year of the coronavirus disease 2019 (COVID-19) pandemic, by US state. (A) Posterior 
distribution of percent increase in deaths from any cause from mid-February 2020 to mid-February 2021. Gold dots show the posterior 
medians. (B) Posterior distribution of excess deaths from any cause per 100,000 people from mid-February 2020 to mid-February 2021. 
Gold dots show the posterior medians. States are ordered vertically by median increase from smallest (at the bottom) to the largest (at the 
top). Colour for each state indicates its geographical region: Alabama, Florida, Georgia, North Carolina, South Carolina, Virginia (Southeast); 
Alaska, Idaho, Oregon, Washington (Northwest); Arizona, Colorado, New Mexico, Utah (Southwest); Arkansas, Kansas, Louisiana, Mississippi, 
Oklahoma, Texas (South); California, Nevada (West); Connecticut, Delaware, District of Columbia, Maine, Maryland, Massachusetts, New 
Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont (Northeast); Illinois, Indiana, Kentucky, Missouri, Ohio, Tennessee, 
West Virginia (Central); Iowa, Michigan, Minnesota, Wisconsin (East North Central); and Montana, Nebraska, North Dakota, South Dakota, 
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Figure 5. Weekly number of deaths from mid-February 2020 through mid-February 2021. The points show reported deaths. The 
turquoise shading shows the credible intervals around the median prediction, from 5% (dark) to 95% (light) in 10% increments.
Figure 6. Weekly percent increase in mortality due to the coronavirus disease 2019 (COVID-19) pandemic by country. The 
turquoise shading shows the credible intervals around the median prediction, from 5% (dark) to 95% (light) in 10% increments. The 
background shading (grey/yellow/orange/red shading under the turquoise ribbons) indicates the magnitude of the weekly increase that 
was detectable with a posterior probability of at least 90%.
had in the first wave. During the same period, Australia, New 
Zealand and Iceland had a mortality deficit compared to levels 
that would have been expected without a pandemic. In Australia 
and New Zealand, which were in winter season in this period, this 
reduction has been attributed to fewer deaths from seasonal flu 
due to reduced contact among people26–29. Chile, the other south-
ern hemisphere country in our analysis, had 12% (8-17) higher 
mortality in the first wave, followed by an even larger increase 
of 21% (15-26) during the (southern hemisphere) winter period.
The subsequent wave(s) of the pandemic (mid-September 2020 
to mid-February 2021) saw yet more changes in excess deaths 
patterns across countries. While New Zealand, Australia, Iceland, 
Finland, Norway, Cyprus and South Korea remained resilient 
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to the rise in mortality (i.e., no or <2% increase in mortal-
ity compared to the no-pandemic baseline), many countries 
in Europe, especially in Central Europe, experienced a rise in 
mortality compared to the no-pandemic baseline: by >40% in 
Slovakia, Czechia and Poland, and by 20-40% in England and 
Wales, Italy, Austria, Hungary, Montenegro, Croatia, Portugal, 
Switzerland, Romania, Lithuania, Bulgaria and Slovenia, 
all with posterior probabilities of positive excess mortality 
greater than 99%. Excess deaths also reappeared in other coun-
tries that had experienced a medium to large toll in the first 
wave including Belgium, Spain, Scotland, Northern Ireland, 
Sweden, Canada, France and the Netherlands – some at the 
same level (France and Northern Ireland) and others at lower 





































































































































































































































































































Mid−February 2020 to May 2020 June 2020 to mid−September 2020 Mid−September 2020 to mid−February 2021
B
Figure 7. Excess mortality due to the coronavirus disease 2019 (COVID-19) pandemic in different time periods. (A) Comparison 
of percent increase in mortality from any cause in excess of what would be expected if there had been no COVID-19 pandemic in summer 
(beginning of June 2020 to mid-September 2020) and subsequent waves (mid-September 2020 to mid-February 2021) with the first wave 
(mid-February 2020 to end of May 2020) in each country. (B) Proportion of excess deaths in each of the above three periods in each country. 
There are no bars for Australia, New Zealand, Norway, Iceland and South Korea in panel B because we estimated no detectable excess 
deaths or a potential reduction in mortality compared to the no-pandemic baseline. Colour for each country indicates its geographical 
region: the Pacific (Australia, New Zealand, South Korea), the Americas (Canada, Chile, the USA), Central and Eastern Europe (Austria, 
Bulgaria, Croatia, Czechia, Estonia, Hungary, Latvia, Lithuania, Montenegro, Poland, Romania, Serbia, Slovakia, Slovenia), Southwestern 
Europe (Cyprus, France, Greece, Italy, Malta, Portugal, Spain), Northwestern Europe (Belgium, England and Wales, Germany, Luxembourg, 
the Netherlands, Northern Ireland, Scotland, Switzerland) and Nordic (Denmark, Finland, Iceland, Norway, Sweden). In some countries, 
there was a reduction in mortality relative to a no-pandemic baseline in some weeks, shown as negative numbers. The country’s total excess 
death toll is the net effect of these reductions and increases in other periods, with all bars adding to 100%. See Figure 6 for weekly percent 
increase in mortality. 
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first wave but all lasting for many weeks during this period. 
The USA had an even larger increase in mortality compared to 
the no-pandemic baseline after mid-September than it had in 
the first wave and summer months, making it the only coun-
try to maintain a steady burden of excess mortality. There 
were nonetheless variations in excess deaths over time across 
different states in the USA (Figure 8).
As a result of these heterogeneous dynamics, there was virtu-
ally no correlation between excess mortality in the first wave 
and the summer period among countries (correlation coefficient 
of percent increase in the two periods = 0.03), and weakly nega-
tive correlation between excess mortality in the first wave and 
mid-September and later (correlation coefficient = -0.15). This 
was translated to a variable distribution of excess mortality 
burden across the three periods (Figure 7B). For example, 
the first wave accounted for over half of excess deaths in 
Scotland, Spain, England and Wales, Canada, Sweden, 
Belgium, the Netherlands and Cyprus. At the other extreme, the 
period between mid-September 2020 and mid-February 2021 
accounted for over 90% of excess deaths in Bulgaria, Croatia, 




















































































































































































































































































































































































































Mid−February 2020 to May 2020 June 2020 to mid−September 2020 Mid−September 2020 to mid−February 2021
B
Figure 8. Excess mortality due to the coronavirus disease 2019 (COVID-19) pandemic in different time periods for US States. 
(A) Comparison of percent increase in mortality from any cause in excess of what would be expected if there had been no COVID-19 
pandemic in summer (beginning of June 2020 to mid-September 2020) and subsequent waves (mid-September 2020 to mid-February 
2021) with the first wave (mid-February 2020 to end of May 2020) in each state. (B) Proportion of excess deaths in each of the above three 
periods in each state. There is no bar for Hawaii because we estimated no detectable excess deaths. In some states, there was a reduction 
in mortality relative to a no-pandemic baseline in some weeks, shown as negative numbers. The state’s total excess death toll is the net 
effect of these reductions and increases in other periods, with all bars adding to 100%. Colour for each state indicates its geographical 
region: Alabama, Florida, Georgia, North Carolina, South Carolina, Virginia (Southeast); Alaska, Idaho, Oregon, Washington (Northwest); 
Arizona, Colorado, New Mexico, Utah (Southwest); Arkansas, Kansas, Louisiana, Mississippi, Oklahoma, Texas (South); California, Nevada 
(West); Connecticut, Delaware, District of Columbia, Maine, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, 
Rhode Island, Vermont (Northeast); Illinois, Indiana, Kentucky, Missouri, Ohio, Tennessee, West Virginia (Central); Iowa, Michigan, Minnesota, 
Wisconsin (East North Central); and Montana, Nebraska, North Dakota, South Dakota, Wyoming (West North Central).
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Slovenia. A similar variation was seen across the US states, with 
excess deaths along the north-eastern coast (Massachusetts, 
New Jersey, Connecticut, New York and District of Columbia) 
being dominated by the first wave, in some southern states 
(Florida, Arizona, Texas and South Carolina) by the summer, 
and in the northern plains (Wisconsin, North and South Dakota 
and Montana) by the post-September period.
Age and sex-distribution of excess mortality
Countries differed in how excess deaths were distributed across 
age groups (Figure 9). In Denmark, Sweden, France, Switzerland, 
Belgium and Slovenia >95% of all excess deaths were in those 
aged 65 years and older. On the other hand, Estonia, Finland 
(which had the smallest detectable excess mortality of any coun-
try), USA, Canada, Lithuania and Chile had the largest share 
of excess deaths in people aged younger than 65 years. Of the 
35 countries with a detectable increase in mortality (defined as 
median estimated increase of >2%) and sufficient data to ana-
lyse by age group, Canada experienced the largest share of 
excess deaths in those aged younger than 45 years (16% of all 
excess deaths), followed by the USA (5%) and Finland (5%; 
noting that excess death rates in Finland, although detectable, 
were lower than in other countries). The high mortality toll in 
younger Canadians may have been due to Covid-19 death at 
home30 and an increase in deaths from drug overdose31. This 
division arises largely from how much specific segments of the 
society, such as workers or care home residents, were exposed 
to infection. Percent increase in mortality was similar between 
men and women in most countries (Figure 10). There were 
nonetheless some exceptions, e.g. in Chile, Montenegro, Serbia 
and the Netherlands deaths increased by a larger percent 
in men (12%-16%) than women (6%-9%); in contrast, in 
Slovenia, women (15%) experienced a slightly larger percent 
increase than men (14%). 
Discussion
The magnitude of excess mortality in the first wave of the 
COVID-19 pandemic was related to two factors. First, how 
well countries, and subnational entities such as US states, 
managed the early months of the pandemic – specifically the agility 
of imposing timely lockdown measures and border controls 
(e.g., complete or partial travel restrictions and/or quarantine 
for travellers) and adequate and effective testing, contact 
tracing and isolation of infected individuals and their 
contacts, and second, how prepared and resilient the health and 
social care system was to control the spread of infection, in the 
community as well as in health facilities and care homes, while 
continuing routine care1,32–37.
Countries eased or maintained travel restrictions and distanc-
ing measures of the first wave to different extents and at different 
paces5,38. They also differed in terms of testing for surveillance 
and identifying infected individuals, how well and how fast 
they traced contacts, and how they supported the isolation 
of infected individuals and their contacts. Australia and New 
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Figure 9. Distribution of excess deaths due to the first year of the coronavirus disease 2019 (COVID-19) pandemic by age group. 
The figure shows the share of excess deaths in each age group by country. There are no bars for Australia, New Zealand, Norway, Iceland 
and South Korea because we estimated no detectable excess deaths or a potential reduction in mortality compared to the no-pandemic 
baseline. There is no bar for Malta because we only made all-age estimates for reasons described in Methods. For Luxembourg, Cyprus, 
Latvia, Northern Ireland, Montenegro and Estonia, analysis was done for 0–64 years without a further split into 0–44 years and 45–64 
years for reasons described in Methods. Colour for each country indicates its geographical region: the Pacific (Australia, New Zealand, 
South Korea), the Americas (Canada, Chile, the USA), Central and Eastern Europe (Austria, Bulgaria, Croatia, Czechia, Estonia, Hungary, 
Latvia, Lithuania, Montenegro, Poland, Romania, Serbia, Slovakia, Slovenia), Southwestern Europe (Cyprus, France, Greece, Italy, Malta, 
Portugal, Spain), Northwestern Europe (Belgium, England and Wales, Germany, Luxembourg, the Netherlands, Northern Ireland, Scotland, 
Switzerland) and Nordic (Denmark, Finland, Iceland, Norway, Sweden).
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approach of disease elimination39 – following strict lockdowns 
they imposed tight border control which kept cases to sporadic 
small numbers and allowed careful contact tracing and isolation. 
Iceland, Norway and South Korea did not close their borders but 
put in place various forms and durations of quarantine/isolation 
and testing for travellers. They also effectively integrated their 
well-coordinated public health capabilities40 with modern 
biomedical (e.g., genomics) and digital technologies (e.g., 
data from credit card transactions, mobile phones and CCTV 
[closed-circuit television] footage), and did widespread 
symptomatic and asymptomatic testing to identify, track and iso-
late infected individuals and their contacts, and to successfully 
suppress the epidemic34,41–46, with additional restrictions only 
when there was a surge in infections. All three countries also 
have a strong healthcare system that continued to provide routine 
care alongside care for COVID-19 patients.
At the other extreme, many countries in Central and Eastern 
Europe, which had put strict measures in place and had expe-
rienced no detectable excess mortality during the first half of 
Figure 10. Excess mortality due to the first year of the coronavirus disease 2019 (COVID-19) pandemic, by country and sex. 
(A) Posterior distribution of percent increase in deaths from any cause from mid-February 2020 to mid-February 2021. Gold dots show 
the posterior medians. (B) Posterior distribution of excess deaths from any cause per 100,000 people from mid-February 2020 to mid-
February 2021. Gold dots show the posterior medians. Countries are ordered vertically by median increase from smallest (at the bottom) 
to the largest (at the top). Data for Northern Ireland, South Korea and USA were only available for both sexes combined and did not allow 
sex-specific results. There are no segments for Malta and Iceland because estimates for these countries were only made for both sexes 
combined, for reasons described in Methods. Colour for each country indicates its geographical region: the Pacific (Australia, New Zealand, 
South Korea), the Americas (Canada, Chile, the USA), Central and Eastern Europe (Austria, Bulgaria, Croatia, Czechia, Estonia, Hungary, 
Latvia, Lithuania, Montenegro, Poland, Romania, Serbia, Slovakia, Slovenia), Southwestern Europe (Cyprus, France, Greece, Italy, Malta, 
Portugal, Spain), Northwestern Europe (Belgium, England and Wales, Germany, Luxembourg, the Netherlands, Northern Ireland, Scotland, 
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2020, removed restrictions on travel and social contact in sum-
mer of 2020, at times to a greater extent or at a faster pace than 
their Western European counterparts38,47,48. With virtually the 
entire population still susceptible to infection, this set into 
motion community transmission, which coincided with the intro-
duction of more transmittable variants of SARS-CoV-2 which 
were not controlled as fast and as strictly as earlier in 2020, 
leading to their true ‘first wave’ in Autumn 2020 which was 
equivalent to or worse than those in their Western European 
counterparts in magnitude and duration (Figure 6 and Figure 7). 
Some Mediterranean countries, such as Malta and Greece, 
and Northwestern European countries, such as Austria and 
Germany, were also largely spared during the first half of 
2020, only to see an increase in deaths in autumn and winter, 
due to a combination of (tourism-related) travel and increased 
local mobility and social interactions49.
Between these extremes, other countries in Europe and Canada 
increased their testing capacity, mandated or encouraged masks 
and face coverings, continued some forms of distancing measures 
(including occasional lockdowns) and restarted some routine 
healthcare. There were also improvements in treatments and 
protocols following large-scale trials and analyses of routine 
care data50–52. These changes meant that, despite the repeated 
rise in infections, the mortality toll from COVID-19 
and other diseases was lower than the first wave but nonetheless 
considerable in these countries50. The continued death toll in 
these countries may have been because distancing measures 
were not as stringent as those in the first wave, and because 
testing, contact tracing and isolation support did not reach the 
coverage or depth needed to contain transmission, as did those 
in Iceland and South Korea42,53. This was compounded by more 
transmittable variants and that the second wave occurred in winter 
when more time is spent indoors with less ventilation. The expe-
rience of the USA did not resemble that of any of the other 
countries. Rather, different states saw a rise in infections and 
deaths at different times54, because there was little coordi-
nated national response and because periods of extensive 
travel, such as Thanksgiving and Christmas holidays, led to 
spread of infection across states.
The observed patterns of excess mortality in the first year of 
the pandemic indicates that the pandemic’s death toll in the 
next year is likely to depend on three factors: The first, and 
most important factor in the countries analysed here will be the 
breadth and pace of vaccination, including whether vaccination 
is extended to school-aged children and the use of boost-
ers to enhance immunity especially against new variants of 
SARS-CoV-2, because vaccines have been shown to be highly 
effective in preventing (severe) COVID-19 and deaths in tri-
als and in real-world settings55–57. Even with high vaccine 
coverage, some adherence to other measures may be needed 
when the number of infections rises, because vaccine efficacy 
is less than 100% and because the morbidity and longer-term 
health morbidity impacts of infection may be significant. Second, 
as the direct impacts of the COVID-19 pandemic are reduced 
through vaccination, the indirect impacts will become more 
visible. These include how much the backlog of routine care 
and persistently high health system pressure impacts deaths 
from other conditions, and the impacts on jobs and income. 
Mitigating these requires economic and social policies that gen-
erate secure employment and income support, and strengthening 
health and social care. A third, and perhaps more uncertain fac-
tor, is the magnitude of direct COVID-19 deaths that might be 
expected in (northern hemisphere) winter 2021-2022 because 
retraction of non-pharmaceutical interventions before the entire 
population is vaccinated may lead to circulating SARS-CoV-2 
infections in countries as a whole as well as in specific 
geographical and sociodemographic subgroups of the popula-
tion. In mid-February 2021, vaccination rates were still low 
in the countries included in our analysis, with the highest 
rates in the UK (22% of adults with one dose and 1% with 
two doses), Serbia (12% and 3%, respectively), the USA 
(11% and 4%, respectively) and Chile (11% and 0.3%, respec-
tively). Since then, vaccination accelerated in industrialised 
countries and emerging economies  and in many countries 70% 
or more of the population have been vaccinated. Even in 
those, specific geographical or social subgroups of the 
population may have lower vaccination rates. Further, for 
much of the world, especially in many low and middle-income 
countries, where access limits the pace of vaccination, the 
remainder of 2021 and 2022 could look as it did for the 
countries in this paper over the past year: a combination of 
extended lockdowns and a large death toll. To avoid this, 
vaccine access and roll out must be accelerated and be 
accompanied with effective actions to both delay and contain 
infections, especially new variants of concern – through a 
combination of travel restrictions and isolation of travellers, 
and effective testing, contact tracing and isolation support.
Strengths and limitations
The main strength of our work is the development and appli-
cation of a method to systematically and consistently use time 
series data from previous years to estimate how many deaths 
would be expected in the absence of pandemic through early 
2021. The models incorporated important features of mortal-
ity, including seasonality of death rates, how mortality in one 
week or year may depend on previous week(s) and year(s), and 
the seasonally-variable role of temperature. To our knowl-
edge, our models are the only ones that formally incorporated 
the role of temperature on weekly mortality, and accounted 
for dependency of mortality in one week on preceding 
week(s) and in one year on preceding year(s). This methodol-
ogy allows more robust estimation of the total impacts of the 
pandemic, especially as more time elapses since the begin-
ning of the pandemic. It also enables comparisons of excess 
deaths across countries on a real-time basis. By modelling death 
rates, rather than simply the number of deaths as is done in most 
other analyses, we account for changes in population size and 
age structure. We used an ensemble of models which typically 
leads to more robust projections and better accounts for both the 
uncertainty associated with each individual model and that of 
model choice. As a result, our approach gives a more complete 
picture of the inherent uncertainty in how many excess deaths 
the pandemic has caused than approaches that are not 
probabilistic or use a single model.
A limitation of our work is that we did not have data on 
underlying cause of death. Having a breakdown of deaths 
by underlying cause will help develop cause-specific models 
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and understand which causes have exceeded or fallen below 
the levels expected. Nor did we have data on total mortal-
ity by individual or community sociodemographic status to 
understand inequalities in the impacts of the pandemic beyond 
deaths assigned to COVID-19 as the underlying cause of 
death. Where data have been analysed for population sub-
groups, excess mortality tends to be higher in marginalised indi-
viduals and communities58–60. More detailed data will allow 
more granular analysis of the impacts of the pandemic, which 
can in turn inform resource allocation and a more targeted 
approach to mitigating both the direct and indirect effects of 
the COVID-19 pandemic.
Comparison with other estimates
Financial Times and The Economist’s excess deaths tracker report 
the number of excess deaths for various countries based on com-
parisons of deaths in 2020 and 2021 with 2015-2019 averages. 
This approach does not account for general trends in mortal-
ity nor for factors like temperature that affect mortality and vary 
from year to year. The Economist has also recently published 
a set of excess deaths estimates using data from the Human 
Mortality Database and the World Mortality Dataset61, and an 
ensemble of gradient boosted decision trees. Countries with 
small, medium and large number of excess deaths are largely 
consistent between our analysis and these sources. There are 
nonetheless some differences. For example, we estimated 
~76,100 excess deaths for Spain, compared to ~88,900 by Finan-
cial Times and ~85,500 by The Economist. Our median excess 
death estimate for Denmark was about twice as large as that 
of Financial Times, and those for Greece and Serbia about 
one third smaller. Similarly, The Economist model predicted 
a mortality deficit of about 3,300 deaths for South Korea, while 
our estimate is that there was no detectable change in mortal-
ity. Nonetheless, the 95% credible interval of our estimates 
contained those of Financial Times and The Economist.
The Institute for Health Metrics and Evaluation has released 
numbers of “total COVID-19 deaths” by fitting a model for sea-
sonality (the details of the seasonal model are not currently 
available) and projecting the residuals for pre-2020 using a 
spline model. The models do not account for temperature, as 
ours do, but hot summer weeks with particularly large deaths 
were excluded. Several sources have commented that the esti-
mates are likely an overestimate62–64. For example, the Insti-
tute estimated ~138,000 deaths for the UK and ~756,000 for the 
USA for the same period as our analysis, compared to ~111,500 
and ~623,100 by us (for comparison, UK national statisti-
cal offices estimated ~118,500 for England, Wales, Scotland 
and Northern Ireland; US CDC estimated ~640,000). They 
estimated ~35,000 deaths for Canada, compared to ~19,800 by 
us and ~19,000 by Statistics Canada, and ~38,000 excess deaths 
for Portugal, compared to ~21,000 by us. EuroMoMo fits 
a sinusoidal seasonal model to death counts but does not 
report country-specific excess deaths and hence could not be 
compared with our results.
The UK Office for National Statistics (ONS) calculated a number 
of age-standardised measures of excess mortality for 15 European 
countries based on comparisons of deaths in 2020 with 
2015-2019 averages65, as did Eurostat for the monthly number 
of deaths. These analyses did not account for temperature and 
holidays, and the Eurostat analysis did not account for changes 
in population. The ONS concluded that Norway, Finland, 
Denmark and Latvia, Cyprus and Estonia had a mortality defi-
cit whereas our estimates indicated no detectable excess mor-
tality for Norway, and increases from 2 to 8% for the other 
countries. Differences between our results and those of the 
ONS may be partly related to the fact that ONS analysis also 
included the pre-pandemic months and did not account for 
interannual variations in temperature. For example, in the north-
ern hemisphere, the first and last three months of 2020 were 
on average warmer than the average of the past five years 
but weeks 13-40 were on average slightly cooler.
Data availability
Underlying data
Input data on deaths, population and temperature are available 
at https://doi.org/10.5281/zenodo.55358298.
This repository contains the following underlying data:
•    data/data.csv (data on deaths, temperature and population 
by age group, sex, country and week)
•    output/result_summaries.csv (weekly estimates of pre-
dicted deaths, excess deaths, excess death rates per 
100,000 and relative increase in deaths)
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
The original data sets used in the study are publicly available 
from the following locations:
Data on deaths and population





ity Statistics, Weekly Dashboard, Jan 2020-May 2021.xlsxand Doc-
tor certified deaths by week of occurrence, 2015-19.xlsx)
Eurostat: https://ec.europa.eu/eurostat/data/database (tables 
demo_r_mwk_05 and demo_pjangroup)
Canada: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid= 




England and Wales: https://www.ons.gov.uk/peoplepopulationand-
community/birthsdeathsandmarriages/deaths/datasets/weeklypro-
visionalfiguresondeathsregisteredinenglandandwales and
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data-portal (time series for category “Total deaths (all causes)” 
and indicator “Weekly deaths by age and sex”)
Northern Ireland: https://www.nisra.gov.uk/publications/histori-
cal-weekly-deaths-data (Historical Weekly Deaths, 2011–2020) 
and https://www.nisra.gov.uk/publications/weekly-death-statistics-





coronavirus-covid-19-in-scotland/related-statistics (Weekly deaths 
by location of death, age group, sex and cause, 2020 and 2021 
and Weekly deaths by sex and age group, 2000 to 2019)










The computer code for the Bayesian model ensemble used in this 
study is available at: https://github.com/vkontis/excess_mortality/
tree/pub2
Archived analysis code at time of publication: https://doi.
org/10.5281/zenodo.55358298.
License: GNU Affero General Public License v3.0
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General comments:
This is an interesting article on the spread of COVID-19 in 40 industrialized countries. 
However, the article has limited information on the lessons learned from these studies. This 
is the major weakness of the study. Qualitative studies should be mentioned. 
 
1. 
Many books have been written on the topic and it would be useful for the authors to look at 
qualitative information from some of them. I would specifically mention the following 
(which I have read (sic) and many others that I could not):
Michael Lewis. The premonition: a pandemic story. 
 
1. 
Niall Ferguson: Doom: the politics of catastrophe. 
 
2. 
Jeremy Farrar and Anjana Ahuja. Spike: The virus vs the people, the inside story. 
 
3. 
Adam Kucharaski. The rules of contagion. 
 
4. 





Would it be worthwhile to add the delta wave epidemic that swept through India, UK and US 
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 The conclusion statement does not mention the lessons missed (NPI, delays, etc).2. 
Methods:
Reference to the “Our World in Data” website is not provided. 
 
1. 
The authors have extensively adjusted for the temperature variation data. This is important 
as this is an important determinant. Two other variables could be important: (a) Age 
distribution of populations in these countries; and (b) Ambient pollution. Data of both are 




Page 7, para 2, line 2: is it mid-February 2021? Please correct.3. 
Results:
Do we have data on excess mortality for US states? May be interesting to add (unless it is 
part of a forthcoming study). 
 
1. 
No data are presented regarding “lessons learned”. May be useful to study the social 
determinants such as GDPs, income, and health systems.
2. 
Discussion:
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expertise to confirm that it is of an acceptable scientific standard, however I have 
significant reservations, as outlined above.
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